Leo Pharma

Founded in Denmark, Leo Pharma has, over the decades, developed world-renowned expertise in the fields of dermatology and thrombosis. As a key player in medical dermatology for over 60 years, we offer a range of medicines marketed in more than 130 countries, with the ambition of meeting the needs of patients whatever the severity of their disease, particularly in psoriasis and atopic dermatitis.

Long neglected, skin health and its systemic dimension still cover grey areas: needs that are not, or not sufficiently, addressed. That's why innovation is at the heart of our raison d'être, to offer patients new therapeutic alternatives. To achieve this, we are stepping up our R&D efforts and reinvesting a large proportion of our profits (23 % in 2021) in research to ensure that our commitments are sustainable.

Patients are Leo Pharma's major concern. They are at the heart of our business, and we deploy all our expertise to meet their needs. This approach applies to the nearly 6 000 employees of Leo Pharma, whatever their position within the company. We are committed to working alongside patients and associations to create an environment where people with dermatological diseases are considered and offered better access to care and solutions to their problems.

At Leo Pharma, we are convinced that only constant mobilisation and a holistic approach can fundamentally change the level of care and quality of life for patients. That's how we've been able to help 89 million patients in 2021. That's our promise to patients. 

https://www.leo-pharma.fr/